Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement.

Pui Y Lee,Brad A Davidson,Roshini S Abraham,Blanche Alter,Juan I Arostegui, Katherine Bell, Alexandre Belot,Jenna R E Bergerson,Timothy J Bernard, Paul A Brogan,Yackov Berkun,Natalie T Deuitch,Dimana Dimitrova, Sophie A Georgin-Lavialle, Marco Gattorno,Bodo Grimbacher,Hasan Hashem,Michael S Hershfield,Rebecca N Ichord,Kazushi Izawa,Jennifer A Kanakry,Raju P Khubchandani,Femke C C Klouwer, Evan A Luton,Ada W Man,Isabelle Meyts,Joris M Van Montfrans,Seza Ozen,Janna Saarela,Gustavo C Santo,Aman Sharma,Ariane Soldatos, Rachel Sparks,Troy R Torgerson, Ignacio Leandro Uriarte,Taryn A B Youngstein,Qing Zhou,Ivona Aksentijevich,Daniel L Kastner,Eugene P Chambers,Amanda K Ombrello

JAMA network open（2023）

Cited 0|Views27

No score

Abstract

DADA2 is a potentially fatal disease that requires early diagnosis and treatment. By summarizing key evidence and expert opinions, these consensus statements provide a framework to facilitate diagnostic evaluation and management of DADA2.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined